INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 152 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $234,000 | -34.3% | 16,800 | -23.1% | 0.00% | 0.0% |
| Q4 2021 | $356,000 | -46.3% | 21,855 | -51.0% | 0.00% | -50.0% |
| Q3 2021 | $663,000 | -44.8% | 44,623 | -25.8% | 0.00% | -60.0% |
| Q2 2021 | $1,200,000 | +81.3% | 60,100 | +109.4% | 0.01% | +66.7% |
| Q1 2021 | $662,000 | +138.1% | 28,704 | +155.3% | 0.00% | +200.0% |
| Q4 2020 | $278,000 | -77.8% | 11,244 | -43.5% | 0.00% | -88.9% |
| Q1 2020 | $1,252,000 | +78.9% | 19,898 | +252.9% | 0.01% | +80.0% |
| Q4 2019 | $700,000 | -10.6% | 5,639 | -52.2% | 0.01% | -28.6% |
| Q3 2019 | $783,000 | +66.6% | 11,800 | +180.8% | 0.01% | +133.3% |
| Q1 2019 | $470,000 | -2.1% | 4,202 | +10.6% | 0.00% | 0.0% |
| Q3 2018 | $480,000 | – | 3,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 640,688 | $14,787,000 | 2.73% |
| DeepCurrents Investment Group LLC | 416,800 | $9,620,000 | 0.33% |
| DUALITY ADVISERS, LP | 105,668 | $2,439,000 | 0.21% |
| EULAV Asset Management | 335,000 | $7,732,000 | 0.21% |
| Virtus ETF Advisers LLC | 19,375 | $447,000 | 0.19% |
| Hennion & Walsh Asset Management, Inc. | 135,214 | $3,121,000 | 0.19% |
| PDT Partners, LLC | 110,592 | $2,552,000 | 0.18% |
| KETTLE HILL CAPITAL MANAGEMENT, LLC | 70,256 | $1,622,000 | 0.16% |
| ALTRINSIC GLOBAL ADVISORS LLC | 168,800 | $3,896,000 | 0.12% |
| WOODWARD DIVERSIFIED CAPITAL, LLC | 8,939 | $206,000 | 0.12% |